Acute ischemic stroke treatment: State of the art

Vascular Medicine

Volumn 16, Issue 1, 2011, Pages 19-28

  Patel, Rajan A G ^a   White, Christopher J ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

acute ischemic stroke; neurovascular intervention; thrombectomy; thrombolytic therapy

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS CLOPIDOGREL; ALTEPLASE; CLOPIDOGREL; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; PLACEBO; RETEPLASE; SARUPLASE; UROKINASE; WARFARIN;

ARTICLE; BRAIN ANGIOGRAPHY; BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN OXYGEN CONSUMPTION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY STENT; DIASTOLIC BLOOD PRESSURE; EMERGENCY WARD; FIBRINOLYTIC THERAPY; GUIDE WIRE; HUMAN; INDUCED HYPOTHERMIA; MAGNETIC RESONANCE ANGIOGRAPHY; MECHANICAL THROMBECTOMY; MIDDLE CEREBRAL ARTERY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECANALIZATION; RECOMMENDED DRUG DOSE; REPERFUSION; REPERFUSION INJURY; STENT; STROKE; SYSTOLIC BLOOD PRESSURE;

ACUTE DISEASE; BRAIN ISCHEMIA; EMERGENCY TREATMENT; HUMANS; PATIENT CARE TEAM; STROKE; THROMBOLYTIC THERAPY;

EID: 79954519452     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358863X10382945     Document Type: Article

References (77)

1. Lloyd-Jones D., Adams RJ, Brown TM, et al. Heart disease and stroke statistics - 2010 update: A report from the American Heart Association. Circulation 2010 ; 121: e46 - e215.
2. Prevalence of disabilities and associated health conditions among adults - United States, 1999. MMWR Morb Mortal Wkly Rep 2001 ; 50: 120-125.
3. Pencina MJ, D'Agostino RB Sr, Larson MG, Massaro JM, Vasan RS Predicting the 30-year risk of cardiovascular disease: The Framingham Heart Study. Circulation 2009 ; 119: 3078-3084.
4. Mauriello A., Sangiorgi GM, Virmani R., et al. A pathobiologic link between risk factors profile and morphological markers of carotid instability. Atherosclerosis 2010 ; 208: 572-580.
5. Schwartz NE, Vertinsky AT, Hirsch KG, Albers GW Clinical and radiographic natural history of cervical artery dissections. J Stroke Cerebrovasc Dis 2009 ; 18: 416-423.
6. Ogata J., Yutani C., Otsubo R., et al. Heart and vessel pathology underlying brain infarction in 142 stroke patients. Ann Neurol 2008 ; 63: 770-781. (Pubitemid 351945536)
7. Adams HP Jr, del Zoppo G., Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 2007 ; 115: e478-534.
8. Kleindorfer D., Kissela B., Schneider A., et al. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: A population-based study. Stroke 2004 ; 35: e27-29.
9. Leonardi-Bee J., Bath PM, Phillips SJ, Sandercock PA Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002 ; 33: 1315-1320. (Pubitemid 34517053)
10. Bruno A., Levine SR, Frankel MR, et al. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 2002 ; 59: 669-674.
11. Azzimondi G., Bassein L., Nonino F., et al. Fever in acute stroke worsens prognosis. A prospective study. Stroke 1995 ; 26: 2040-2043.
12. Reith J., Jorgensen HS, Pedersen PM, et al. Body temperature in acute stroke: Relation to stroke severity, infarct size, mortality, and outcome. Lancet 1996 ; 347: 422-425. (Pubitemid 26054066)
13. Kidwell CS, Chalela JA, Saver JL, et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 2004 ; 292: 1823-1830. (Pubitemid 40169292)
14. Wardlaw JM, Mielke O. Early signs of brain infarction at CT: Observer reliability and outcome after thrombolytic treatment - systematic review. Radiology 2005 ; 235: 444-453. (Pubitemid 40571081)
15. Eckert B., Kucinski T., Neumaier-Probst E., Fiehler J., Rother J., Zeumer H. Local intra-arterial fibrinolysis in acute hemispheric stroke: Effect of occlusion type and fibrinolytic agent on recanalization success and neurological outcome. Cerebrovasc Dis 2003 ; 15: 258-263. (Pubitemid 36438729)
16. Rubiera M., Ribo M., Delgado-Mederos R., et al. Tandem internal carotid artery/middle cerebral artery occlusion: An independent predictor of poor outcome after systemic thrombolysis. Stroke 2006 ; 37: 2301-2305. (Pubitemid 44337173)
17. Zaidat OO, Suarez JI, Santillan C., et al. Response to intraarterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion. Stroke 2002 ; 33: 1821-1826. (Pubitemid 34761068)
18. Klingebiel R., Siebert E., Diekmann S., et al. 4-D Imaging in cerebrovascular disorders by using 320-slice CT: Feasibility and preliminary clinical experience. Acad Radiol 2009 ; 16: 123-129.
19. Siebert E., Bohner G., Dewey M., et al. 320-slice CT neuroimaging: Initial clinical experience and image quality evaluation. Br J Radiol 2009 ; 82: 561-570.
20. Diekmann S., Siebert E., Juran R., et al. Dose exposure of patients undergoing comprehensive stroke imaging by multidetector-row CT: Comparison of 320-detector row and 64-detector row CT scanners. AJNR Am J Neuroradiol 2010 ; 31: 1003-1009.
21. Furlan AJ, Eyding D., Albers GW, et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): Evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006 ; 37: 1227-1231. (Pubitemid 43731867)
22. Hacke W., Albers G., Al- Rawi Y., et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005 ; 36: 66-73. (Pubitemid 40054177)
23. Hacke W., Furlan AJ, Al- Rawi Y., et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): A prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009 ; 8: 141-150.
24. Kohrmann M., Juttler E., Fiebach JB, et al. MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: A cohort study. Lancet Neurol 2006 ; 5: 661-667. (Pubitemid 44062409)
25. Lev MH, Segal AZ, Farkas J., et al. Utility of perfusion-weighted CT imaging in acute middle cerebral artery stroke treated with intra-arterial thrombolysis: Prediction of final infarct volume and clinical outcome. Stroke 2001 ; 32: 2021-2028.
26. Mishra NK, Albers GW, Davis SM, et al. Mismatch-based delayed thrombolysis: A meta-analysis. Stroke 2010 ; 41: e25-33.
27. Soares BP, Chien JD, Wintermark M. MR and CT monitoring of recanalization, reperfusion, and penumbra salvage: everything that recanalizes does not necessarily reperfuse! Stroke 2009 ; 40: S24 - S27.
28. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW 1,026 experimental treatments in acute stroke. Ann Neurol 2006 ; 59: 467-477. (Pubitemid 43358067)
29. Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002 ; 346: 549-556.
30. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002 ; 346: 557-563. (Pubitemid 34438816)
31. Aronowski J., Strong R., Shirzadi A., Grotta JC Ethanol plus caffeine (caffeinol) for treatment of ischemic stroke: Preclinical experience. Stroke 2003 ; 34: 1246-1251. (Pubitemid 36547523)
32. Hemmen TM, Lyden PD Multimodal neuroprotective therapy with induced hypothermia after ischemic stroke. Stroke 2009 ; 40: S126-128.
33. Zausinger S., Scholler K., Plesnila N., Schmid-Elsaesser R. Combination drug therapy and mild hypothermia after transient focal cerebral ischemia in rats. Stroke 2003 ; 34: 2246-2251. (Pubitemid 37099844)
34. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995 ; 333: 1581-1587.
35. Kwiatkowski TG, Libman RB, Frankel M., et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med 1999 ; 340: 1781-1787.
36. Albers GW, Clark WM, Madden KP, Hamilton SA ATLANTIS trial: Results for patients treated within 3 hours of stroke onset. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. Stroke 2002 ; 33: 493-495.
37. Clark WM, Wissman S., Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: A randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999 ; 282: 2019-2026.
38. Hacke W., Kaste M., Fieschi C., et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995 ; 274: 1017-1025.
39. Albers GW, Bates VE, Clark WM, Bell R., Verro P., Hamilton SA Intravenous tissue-type plasminogen activator for treatment of acute stroke: The Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 2000 ; 283: 1145-1150. (Pubitemid 30126602)
40. Hill MD, Buchan AM Thrombolysis for acute ischemic stroke: Results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ 2005 ; 172: 1307-1312. (Pubitemid 40745072)
41. Hacke W., Donnan G., Fieschi C., et al. Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004 ; 363: 768-774.
42. Reeves MJ, Arora S., Broderick JP, et al. Acute stroke care in the US: Results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke 2005 ; 36: 1232-1240. (Pubitemid 40798745)
43. Hacke W., Kaste M., Bluhmki E., et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008 ; 359: 1317-1329.
44. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009 ; 40: 2945-2948.
45. Furlan A., Higashida R., Wechsler L., et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999 ; 282: 2003-2011.
46. Ogawa A., Mori E., Minematsu K., et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007 ; 38: 2633-2639. (Pubitemid 47493996)
47. The Interventional Management of Stroke (IMS) II Study. Stroke 2007 ; 38: 2127-2135.
48. Wolfe T., Suarez JI, Tarr RW, et al. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke. J Stroke Cerebrovasc Dis 2008 ; 17: 121-128. (Pubitemid 351626608)
49. McDougall C., Clark W., Mayer T., et al. The Penumbra Stroke Trial: Safety and effectiveness of a new generation of mechanical device for clot removal in acute ischemic stroke. Stroke 2008 ; LB4 [abstract].
50. Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009 ; 40: 2761-2768.
51. Bose A., Henkes H., Alfke K., et al. The Penumbra System: A mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 2008 ; 29: 1409-1413.
52. Gobin YP, Starkman S., Duckwiler GR, et al. MERCI 1: a phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke 2004 ; 35: 2848-2854.
53. Smith WS, Sung G., Starkman S., et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005 ; 36: 1432-1438. (Pubitemid 40967507)
54. Smith WS, Sung G., Saver J., et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008 ; 39: 1205-1212. (Pubitemid 351440692)
55. Nogueira RG, Liebeskind DS, Sung G., Duckwiler G., Smith WS Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials. Stroke 2009 ; 40: 3777-3783.
56. Vemmos KN, Takis CE, Georgilis K., et al. The Athens stroke registry: results of a five-year hospital-based study. Cerebrovasc Dis 2000 ; 10: 133-141. (Pubitemid 30107508)
57. Barnett HJ, Gunton RW, Eliasziw M., et al. Causes and severity of ischemic stroke in patients with internal carotid artery stenosis. JAMA 2000 ; 283: 1429-1436. (Pubitemid 30151821)
58. Levy EI, Ecker RD, Horowitz MB, et al. Stent-assisted intracranial recanalization for acute stroke: early results. Neurosurgery 2006 ; 58: 458-463 ; discussion 458-463.
59. Fiorella DJ, Levy EI, Turk AS, et al. Target lesion revascularization after wingspan: assessment of safety and durability. Stroke 2009 ; 40: 106-110.
60. Levy EI, Turk AS, Albuquerque FC, et al. Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery 2007 ; 61: 644-650 ; discussion 650-651. (Pubitemid 47442683)
61. Turk AS, Levy EI, Albuquerque FC, et al. Influence of patient age and stenosis location on wingspan in-stent restenosis. AJNR Am J Neuroradiol 2008 ; 29: 23-27.
62. Brekenfeld C., Schroth G., Mattle HP, et al. Stent placement in acute cerebral artery occlusion: use of a self-expandable intracranial stent for acute stroke treatment. Stroke 2009 ; 40: 847-852.
63. Levy EI, Mehta R., Gupta R., et al. Self-expanding stents for recanalization of acute cerebrovascular occlusions. AJNR Am J Neuroradiol 2007 ; 28: 816-822. (Pubitemid 46776054)
64. Mocco J., Hanel RA, Sharma J., et al. Use of a vascular reconstruction device to salvage acute ischemic occlusions refractory to traditional endovascular recanalization methods. J Neurosurg 2010 ; 112: 557-562.
65. Zaidat OO, Wolfe T., Hussain SI, et al. Interventional acute ischemic stroke therapy with intracranial self-expanding stent. Stroke 2008 ; 39: 2392-2395.
66. Levy EI, Siddiqui AH, Crumlish A., et al. First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke). Stroke 2009 ; 40: 3552-3556.
67. Hauck EF, Mocco J., Snyder KV, Levy EI Temporary endovascular bypass: a novel treatment for acute stroke. AJNR Am J Neuroradiol 2009 ; 30: 1532-1533.
68. Kelly ME, Furlan AJ, Fiorella D. Recanalization of an acute middle cerebral artery occlusion using a self-expanding, reconstrainable, intracranial microstent as a temporary endovascular bypass. Stroke 2008 ; 39: 1770-1773.
69. Suh SH, Lee KY, Hong CK, et al. Temporary stenting and retrieval of the self-expandable, intracranial stent in acute middle cerebral artery occlusion. Neuroradiology 2009 ; 51: 541-544.
70. Mathews MS, Sharma J., Snyder KV, et al. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset. Neurosurgery 2009 ; 65: 860-865 ; discussion 865.
71. Higashida RT, Furlan AJ, Roberts H., et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003 ; 34: e109-137.
72. Suzuki S., Saver JL, Scott P., et al. Access to intra-arterial therapies for acute ischemic stroke: an analysis of the US population. AJNR Am J Neuroradiol 2004 ; 25: 1802-1806. (Pubitemid 44123711)
73. DeVries JT, White CJ, Cunningham MC, Ramee SR Catheter-based therapy for acute ischemic stroke: a national unmet need. Catheter Cardiovasc Interv 2008 ; 72: 705-709.
74. Alberts MJ, Latchaw RE, Selman WR, et al. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke 2005 ; 36: 1597-1616. (Pubitemid 40973803)
75. George MG, Tong X., McGruder H., et al. Paul Coverdell National Acute Stroke Registry Surveillance - four states, 2005-2007. MMWR Surveill Summ 2009 ; 58: 1-23.
76. Reeves MJ, Smith E., Fonarow G., Hernandez A., Pan W., Schwamm LH Off-hour admission and in-hospital stroke case fatality in the Get With The Guidelines-Stroke program. Stroke 2009 ; 40: 569-576.
77. Saposnik G., Baibergenova A., Bayer N., Hachinski V. Weekends: a dangerous time for having a stroke? Stroke 2007 ; 38: 1211-1215. (Pubitemid 351664241)